Background illustration for clinical trials search

Multiple Sclerosis Clinical Trials

Browse 309 multiple sclerosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple Sclerosis

for
Multiple Sclerosis
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 21 - 70

Code: NCT06552611

Phase 1, Recruiting
Active & Responsive

Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue

for
Multiple Sclerosis
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06809192

Recruiting
Active & ResponsiveNew

Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease

for
Thyroid Eye Disease (TED), Graves' Disease,
Location: Wilmington NC, Orland Park IL
Sponsor: Ethyreal Bio, Inc.

Sex: All

Age: 18+

Code: NCT07885605

Phase 1, Recruiting
Active & Responsive

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

for
Diabetes Mellitus, Type 1, Hypoglycemia,
Location: Chicago IL
Sponsor: Otsuka Pharmaceutical Factory, Inc.

Sex: All

Age: 35 - 70

Code: NCT06575426

Phase 1, Phase 2, Recruiting
Active & Responsive

The Neurodevelopmental and Behavioral Phenotyping Screening Protocol

for
Neurologic Disorders, Autism, Neurodegenerative Disease,
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 0+

Code: NCT00271622

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Investigating Health Impacts of Exposure to Harmful Algal Blooms

for
Red Tide, Neurologic Disorder, Florida
Location: Sarasota FL
Sponsor: Roskamp Institute Inc.

Sex: All

Age: 18+

Code: NCT06883227

Recruiting
Active & Responsive

Transcutaneous Stimulation for Neurological Populations

for
Neurological Disorder, Cerebral Palsy
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 4 - 70

Code: NCT04467437

Recruiting
Active & Responsive

VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

for
Autoimmune Diseases, Epilepsy, Autonomic Dysfunction,
Location: Louisville KY, Salt Lake City UT
Sponsor: University of Louisville

Sex: All

Age: 0 - 60

Code: NCT03953768

Recruiting
Active & Responsive

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

for
Rare Disorders, Undiagnosed Disorders,
Location: Sioux Falls SD
Sponsor: Sanford Health

Sex: All

Age: 0+

Code: NCT01793168

Recruiting
Active & ResponsiveNew

Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel

for
B-cell Mediated Autoimmune Disorders
Location: Morrisville NC
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 62

Code: NCT07577583

Recruiting
Active & Responsive

Daratumumab in Primary Antiphospholipid Syndrome

for
Autoimmune Disorders
Location: Great Neck NY, New York NY, Baltimore MD, Durham NC,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 65

Code: NCT05671757

Phase 1, Phase 2, Recruiting
Active & Responsive

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

for
Parkinson Disease, Prodromal Stage, Neurodegenerative Diseases,
Location: Rochester NY
Sponsor: Radboud University Medical Center

Sex: All

Age: 50+

Code: NCT06993142

Recruiting
Active & Responsive

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma, Lymphoma Non-Hodgkin, B-cell Lymphoma,
Location: Bethesda MD
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All

Age: 4+

Code: NCT07652580

Recruiting
Active & Responsive

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Boston MA, Hackensack NJ, Tampa FL, Atlanta GA,
Sponsor: Kelonia Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07075185

Phase 1, Recruiting
Active & Responsive

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

for
Autoimmune Disorders
Location: Baltimore MD, Birmingham AL, Chicago IL, Rochester MN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT07103746

Phase 2, Recruiting
Active & Responsive

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

for
Common Variable Immunodeficiency (CVID),
Location: Pittsburgh PA
Sponsor: Paul Szabolcs

Sex: All

Age: 5 - 40

Code: NCT07284641

Phase 2, Recruiting
Active & Responsive

The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

for
Insulin Dependent Diabetes Mellitus,
Location: Montreal
Sponsor: McGill University

Sex: All

Age: 12+

Code: NCT07348432

Recruiting
Active & Responsive

Registry and Natural History of Epilepsy-Dyskinesia Syndromes

for
Epilepsy-Dyskinesia, Epilepsy, Dyskinesia, EDS,
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 0 - 30

Code: NCT06967727

Recruiting

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

for
Multiple Sclerosis, Pathologic Processes,
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 18 - 70+

Code: NCT07759115

Recruiting

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

for
Demyelinating Disorders, MCI, Alzheimer's Disease (AD),
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 70+

Code: NCT06999434

Phase 1, Recruiting

What is multiple sclerosis?

In MS, the immune system attacks myelin, the insulation around nerve fibers in the brain and spinal cord. Damaged spots, called lesions, slow or block nerve signals, which is why symptoms range from fatigue and numbness to vision problems and trouble walking. Symptoms and pace differ so much between people that MS is often called a disease with a thousand faces. It is not contagious, and it is not directly inherited. Worldwide about 2.9 million people live with MS, someone is diagnosed roughly every five minutes, and the average age at diagnosis is 32.

Research in this field carries one of the most striking findings in modern medicine: a 2022 study of more than 10 million US military members found that infection with the Epstein Barr virus, the common virus behind mononucleosis, raises MS risk 32 times, making it the leading suspected cause. Meanwhile treatment keeps expanding, with more than 20 approved disease modifying therapies, though the progressive forms still have almost none.

Article preview image

Interested in learning more about MS treatment? Read our guide: Multiple Sclerosis Treatment: 20+ Drugs and What's Next

Why Progressive Multiple Sclerosis Still Has Almost No Approved Treatments

The types of MS, and why they matter for trials

Types of multiple sclerosis clinical trials

Who can participate in MS trials?

Do MS trial participants get paid?

How to enroll in a clinical trial for multiple sclerosis